These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 218135)

  • 21. Behavioral effects of intraaccumbens transplants in rats with lesions of the mesocorticolimbic dopamine system.
    Choulli K; Herman JP; Abrous N; Le Moal M
    Ann N Y Acad Sci; 1987; 495():497-509. PubMed ID: 3474956
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low doses of accumbens dopamine modulate amygdala suppression of spontaneous exploratory activity in rats.
    Yim CY; Mogenson GJ
    Brain Res; 1989 Jan; 477(1-2):202-10. PubMed ID: 2649208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of catecholamines on locomotor activity and cyclic AMP in nucleus accumbens in rats.
    Vance MA; Blumberg JB
    J Pharm Pharmacol; 1983 Jun; 35(6):402-4. PubMed ID: 6135789
    [No Abstract]   [Full Text] [Related]  

  • 28. Decrease in levels of thyrotrophin-releasing hormone (TRH) in the n. accumbens and lumbar spinal cord following repeated electroconvulsive shock.
    Lighton C; Marsden CA; Bennett GW; Minchin M; Green AR
    Neuropharmacology; 1984 Aug; 23(8):963-6. PubMed ID: 6435006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat.
    Jones DL; Mogenson GJ; Wu M
    Neuropharmacology; 1981 Jan; 20(1):29-37. PubMed ID: 6261181
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective involvement of dopamine in the nucleus accumbens in the feeding response elicited by muscimol injection in the nucleus raphe dorsalis of sated rats.
    Bendotti C; Berettera C; Invernizzi R; Samanin R
    Pharmacol Biochem Behav; 1986 May; 24(5):1189-93. PubMed ID: 2425377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.
    Arnt J
    Life Sci; 1981 Apr; 28(14):1597-603. PubMed ID: 6264256
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR; Melville GN; Wenger T; Louden D
    West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo voltammetric and behavioural evidence for somatodendritic autoreceptor control of mesolimbic dopamine neurones.
    Maidment NT; Marsden CA
    Brain Res; 1985 Jul; 338(2):317-25. PubMed ID: 2992688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior.
    Austin MC; Kalivas PW
    Brain Res; 1988 Feb; 441(1-2):209-14. PubMed ID: 3359231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock.
    Smith SE; Acton L; Sharp T
    Psychopharmacology (Berl); 1997 Sep; 133(1):85-94. PubMed ID: 9335085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D; Asin KE; Kent EW
    Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.